Modest Visceral Fat Gain Causes Endothelial Dysfunction in Healthy Humans  by Romero-Corral, Abel et al.
JT
a
A
T
a
E
p
a
C
e
M
T
1
2
3
4
C
a
o
C
D
D
s
I
f
s
J
E
S
e
Journal of the American College of Cardiology Vol. 56, No. 8, 2010
© 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
PEndothelial Function and Visceral Fat
CMEModest Visceral Fat Gain Causes
Endothelial Dysfunction in Healthy Humans
Abel Romero-Corral, MD, MS,* Fatima H. Sert-Kuniyoshi, PHD,* Justo Sierra-Johnson, MD, PHD,‡
Marek Orban, MD,* Apoor Gami, MD,* Diane Davison, RN,* Prachi Singh, PHD,*
Snigdha Pusalavidyasagar, MD,* Christine Huyber,* Susanne Votruba, PHD,†
Francisco Lopez-Jimenez, MD, MSC,* Michael D. Jensen, MD,† Virend K. Somers, MD, PHD*
Rochester, Minnesota; and Stockholm, Sweden
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.03.063C
M
i
A
p
(
0
J
o
a
(
w
A
S
t
D
l
i
f
O
D
d
M
q
C
IACC JOURNAL CME
his article has been selected as the month’s JACC Journal CME
ctivity.
ccreditation and Designation Statement
he American College of Cardiology Foundation (ACCF) is
ccredited by the Accreditation Council for Continuing Medical
ducation (ACCME) to provide continuing medical education for
hysicians.
The American College of Cardiology designates the educational
ctivities in JACC for a maximum of 1 AMA PRA Category 1
redit. Physicians should only claim credit commensurate with the
xtent of their participation in the activity.
ethod of Participation and Receipt of CME Certificate
o obtain credit for JACC CME, you must:
. Be an ACC member or JACC subscriber
. Carefully read and reflect upon the CME-designated article
available online and in this issue of JACC.
. Answer the post-test questions and complete the brief evalua-
tion available at http://cme.jaccjournals.org.
. Claim your CME credit and receive your certificate electroni-
cally by following the instructions given at the conclusion of
the online activity.
ME Objective for This Article: At the conclusion of this
ctivity, the learner should be able to identify the effects of fat gaintudy of Diabetes (Düsseldorf, Germany) through a research fellowship, and is an
mployee of Eli Lilly Company. Dr. Singh was supported by grant 0725787Z from the
A
D
b
(
p
J
K
P
n
2ME Editor Disclosure: JACC CME Editor Ajit Raisinghani,
D, FACC, reports that he has no financial relationships or
nterests to disclose.
uthor Disclosures: Dr. Romero-Corral was supported by a
ostdoctoral fellowship from the American Heart Association
Dallas, Texas). Dr. Sert-Kuniyoshi was supported by grant
9-20069G from the American Heart Association. Dr. Sierra-
ohnson was partially supported by faculty funds from the Board
f Post-Graduate Education of Karolinska Institutet (KID Award)
nd by the European Foundation for the Study of Diabetes
Düsseldorf, Germany) through a research fellowship. Dr. Singh
as supported by grant 0725787Z from the American Heart
ssociation. Dr. Lopez-Jimenez is a recipient of a Clinical
cientist Development Award from the American Heart Associa-
ion. Dr. Somers was supported by grants R01 HL73211 and R21
K81014 from the National Institutes of Health (Bethesda, Mary-
and). Drs. Romero-Corral, Somers, and Lopez-Jimenez are recip-
ents of a grant from Select Research (Suckley, United Kingdom)
or separate work related to the measurement of obesity. Drs.
rban, Gami, Pusalavidyasagar, Votruba, and Jensen and Ms.
avison and Huyber report that they have no relationships to
isclose.
edium of Participation: Print (article only); online (article and
uiz)
ME Term of Approval:
ssue date: August 17, 2010n endothelial function. Expiration date: August 16, 2011merican Heart Association. Dr. Lopez-Jimenez is a recipient of a Clinical Scientist
evelopment Award from the American Heart Association. Dr. Somers was supported
y grants R01 HL73211 and R21 DK81014 from the National Institutes of Health
Bethesda, Maryland) and is working with Mayo Health Solutions on intellectual
roperty related to obesity and cardiovascular disease. Drs. Romero-Corral, Lopez-
imenez, and Somers are recipients of a grant from Select Research (Suckley, United
ingdom) for separate work related to the measurement of obesity. Drs. Orban, Gami,
usalavidyasagar, Votruba, and Jensen and Ms. Davison and Huyber report that they have
o relationships to disclose.ontinuing Medical Education (CME) is available for this article. From the
ivisions of *Cardiovascular Diseases and the †Endocrinology and Metabolism,
epartment of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minne-
ota; and the ‡Department of Medicine, Atherosclerosis Research Unit, Karolinska
nstitutet, Stockholm, Sweden. Dr. Romero-Corral was supported by a postdoctoral
ellowship from the American Heart Association (Dallas, Texas). Dr. Sert-Kuniyoshi was
upported by grant 09-20069G from the American Heart Association. Dr. Sierra-
ohnson was partially supported by faculty funds from the Board of Post-Graduate
ducation of Karolinska Institutet (KID Award) and by the European Foundation for theManuscript received December 16, 2009; revised manuscript received February 22,
010, accepted March 9, 2010.
ME
a
a
d
h
i
w
c
e
a
t
c
v
h
g
t
l
M
W
i
e
a
s
b
F
w
d
663JACC Vol. 56, No. 8, 2010 Romero-Corral et al.
August 17, 2010:662–6 Fat Gain and Endothelial Dysfunctionodest Visceral Fat Gain Causes Endothelial Dysfunction in Healthy Humans
Objectives The aim of this study was to determine the impact of fat gain and its distribution on endothelial function in lean
healthy humans.
Background Endothelial dysfunction has been identified as an independent predictor of cardiovascular events. Whether fat
gain impairs endothelial function is unknown.
Methods A randomized controlled study was conducted to assess the effects of fat gain on endothelial function. Forty-
three normal-weight healthy volunteers were recruited (mean age 29 years; 18 women). Subjects were assigned
to gain weight (approximately 4 kg) (n  35) or to maintain weight (n  8). Endothelial function (brachial artery
flow-mediated dilation [FMD]) was measured at baseline, after fat gain (8 weeks), and after weight loss (16 weeks)
for fat gainers and at baseline and follow-up (8 weeks) for weight maintainers. Body composition was measured by
dual-energy X-ray absorptiometry and abdominal computed tomographic scans.
Results After an average weight gain of 4.1 kg, fat gainers significantly increased their total, visceral, and subcutaneous
fat. Blood pressure and overnight polysomnography did not change after fat gain or loss. FMD remained un-
changed in weight maintainers. FMD decreased in fat gainers (9.1  3% vs. 7.8  3.2%, p  0.003) but recov-
ered to baseline when subjects shed the gained weight. There was a significant correlation between the de-
crease in FMD and the increase in visceral fat gain (rho  0.42, p  0.004), but not with subcutaneous fat
gain (rho  0.22, p  0.15).
Conclusions In normal-weight healthy young subjects, modest fat gain results in impaired endothelial function, even in the
absence of changes in blood pressure. Endothelial function recovers after weight loss. Increased visceral rather
than subcutaneous fat predicts endothelial dysfunction. (Fat Gain and Cardiovascular Disease Mechanisms;
NCT00589498) (J Am Coll Cardiol 2010;56:662–6) © 2010 by the American College of Cardiology Foundationg
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undothelial dysfunction is considered a systemic process
nd an early event in the atherosclerotic process (1). Brachial
rtery flow-mediated dilation (FMD) reflects coronary en-
othelial function (2,3) and has been associated with a
igher prevalence of coronary artery disease (1) and is an
ndependent predictor of cardiovascular events in patients
ith and without established atherosclerosis (4,5).
Increased body fat has been linked to a higher risk for
ardiovascular disease. Previous studies assessing obesity and
ndothelial dysfunction have been cross-sectional in nature,
nd thus no causal interaction can be defined (6,7). Al-
hough visceral obesity is predictive of increased cardiovas-
ular risk, there are no data on the interactions between
isceral obesity and endothelial function. We tested the
ypothesis that endothelial function is impaired after weight
ain and recovers after reversal of weight gain. We also
ested the hypothesis that impaired endothelial function is
inked to visceral or subcutaneous fat accumulation.
ethods
e recruited 43 healthy volunteers with baseline body mass
ndexes (BMIs) of 18.5 to 24.9 kg/m2. Subjects were
xcluded if they were smokers, were pregnant, were taking
ny medication, or had any acute or chronic illness. This
tudy was approved by the Mayo Clinic institutional review
oard, and all subjects provided written informed consent.
at gainer and weight maintainer protocols. After a
eight maintenance period of 3 days, subjects were ran-
omly assigned to be in the fat gainer or weight maintainer sroup, with a 20% chance of being a weight maintainer. For
he fat gainer group, for the first 8 weeks, each subject
eceived 1,000 kcal/day (40% carbohydrate, 40% fat, and
0% protein) in addition to weight maintenance require-
ents. The goal was to gain 3 to 4 kg of total body fat (a 5%
ncrease in weight). After the fat gain, subjects underwent a
iet program to return to their basal weights. Dietary
ounseling was available to all participants, and their
eights were monitored by a dietitian throughout the study.
xercise treadmill testing was conducted to assess changes
n levels of physical fitness during the study.
ody composition. We measured height by wall stadiom-
ter, weight by electronic scale, and waist and hip circumfer-
nces by nonelastic tape. The volunteers underwent computed
omographic measures of visceral fat area (single-slice com-
uted tomography at the L2 to L3 interspace) and dual-energy
-ray absorptiometry (Lunar Radiation, Madison, Wisconsin)
t baseline and after 8 weeks for both groups and after weight
oss (16 weeks) for fat gainers. For logistic reasons, computed
omographic and dual-energy X-ray absorptiometry measures
ere obtained in all 35 subjects before and after weight gain
nd in 16 subjects after weight loss.
ascular studies. All subjects were asked to abstain from
lcohol and caffeine for 24 h before the study. Subjects
nderwent complete overnight polysomnography to exclude
he development of sleep apnea using the apnea-hypopnea
ndex (events/h) (8) with weight gain. FMD was measured in
he morning with the subjects fasting, with high-resolution
ltrasound following a standard protocol as previously de-
cribed (9).
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Fat Gain and Endothelial Dysfunction August 17, 2010:662–6Blood measurements. Blood sam-
ples were obtained at the 3 time
points. Leptin was measured using
a radioimmunoassay kit (Linco
Research, Inc., St. Louis, Mis-
souri), insulin was measured us-
ing a 2-site immunoenzymatic
assay (Beckman Instruments, Inc.,
haska, Minnesota), adiponectin was measured using an
nzyme-linked immunosorbent assay kit (Mediagnost
mbH, Reutlingen, Germany), glucose was measured using
exokinase reagent using a Hitachi 912 chemistry analyzer
Boehringer Mannheim, Indianapolis, Indiana), and lipid
rofile (cholesterol, triglycerides, and high-density lipopro-
ein) was measured using the standard turbidometry method
n a Hitachi 912 chemistry analyzer (Roche Diagnostics
mbH, Mannheim, Germany). High-sensitivity C-reactive
rotein (CRP) was measured on a Hitachi 912 chemistry
nalyzer using a polystyrene particle-enhanced immuno-
urbidometric assay (DiaSorin, Saluggia, Italy).
tatistical analysis. Data are summarized as mean  SD
or quantitative variables and as numbers and percents for
ategorical variables. The changes between baseline and
fter 8 weeks were compared using paired t test analyses. An
dditional analysis was performed for fat gainers after
eight loss. We used an unpaired t test to compare fat
Abbreviations
and Acronyms
BMI  body mass index
CRP  C-reactive protein
FMD  flow-mediated
dilation
ubject Characteristics at Baseline and During the Fat Gainer andTable 1 Subject Characteristics at Baseline and During the Fat
Variable
Fat Gainers
Baseline Fat Ga
Age (yrs) 29.6 7.1 —
Women 13 (37.1%) —
Systolic blood pressure (mm Hg) 116.2 13.0 117.4 1
Diastolic blood pressure (mm Hg) 70.3 9.7 69.4 9
Heart rate (beats/min) 62.2 10.0 66.7 1
Weight (kg) 70.8 13.0 75.1 1
BMI (kg/m2) 23.1 2.9 24.6 3
Waist circumference (cm) 83.2 7.5 86.2 7
Hip circumference (cm) 97.2 4.7 100.7 5
Body fat (%) 25.7 9.5 28.3 9
Total body fat area (cm2) 164 78 206.8 8
Subcutaneous fat area (cm2) 116.7 57 146.6 6
Visceral fat area (cm2) 47.3 31.4 60.1 3
Apnea-hypopnea index (events/h) 0.64 1.1 0.56 0
Insulin (U/ml) 4.5 1.8 6.2 3
Glucose (mg/dl) 94 8 95 1
Leptin (ng/ml) 6.8 5.5 11.4 8
Adiponectin (ng/ml) 8,376 3,772 9,179 4
CRP (mg/dl) 0.03 0.02 0.06 0
Cholesterol (mg/dl) 155 24 160 3
HDL (mg/dl) 37 10 36.0 9
Triglycerides (mg/dl) 82 29 95 5
FMD % change 9.02 2.8 7.86 3
Computed tomographic and dual-energy X-ray absorptiometry measures were obtained in only 16
aseline. CRP levels were obtained in 14 of the 35 subjects. Some patients had CRP levels 0.0
omparisons: ¶p  0.05.
BMI  body mass index; CRP  C-reactive protein; FMD  flow-mediated dilation; HDL  high-densityainers and weight maintainers at baseline and at 8 weeks (a
onparametric test showed similar results). Because of the
onlinearity of the data, we used Spearman’s correlation
oefficients between the changes in FMD with total, vis-
eral, and subcutaneous fat gain, and changes in cardio-
etabolic biomarkers.
Finally, we divided into tertiles the amount of visceral and
ubcutaneous fat gained to assess the relationship between
agnitude of fat gain and changes in FMD among fat
ainers. Data were analyzed using JMP (SAS Institute Inc.,
ary, North Carolina). Two-tailed p values 0.05 were
onsidered significant. Bonferroni’s correction was used to
djust for multiple comparisons, and a 2-tailed p  0.016
as considered significant.
esults
e recruited 43 lean healthy volunteers, 35 fat gainers and
weight maintainers. The mean age was 29  6 years, and
8 (42%) were women. Fat gainers were slightly older than
eight maintainers (age 26  3 years vs. 29  7 years, p 
.05), but there were no other significant differences be-
ween the 2 groups (Table 1).
eight maintainers. There were no differences in any
ariable measured between baseline and 8 weeks after the
eight maintenance period (Table 1).
ht Maintainer Protocolser and Weight Maintainer Protocols
5) Weight Maintainers (n  8)
Recovery* Baseline Follow-Up
— 26 3.5 —
— 5 (62.5%) —
116.5 13.5 114.2 11 111.7 7.6
70.0 8.1 69.0 6.2 70.3 9.7
64.3 12.0 67.3 11.0 67.5 13.5
72.1 12.9 66.6 13.0 66.6 13.5
23.5 2.7 22.3 1.9 22.3 1.8
84.0 8.1 76.8 8.1 77.5 8.5
98.1 6.2 95.5 4.0 95.8 4.2
26.3 9.5 25.9 5.8 26.2 5.4
171 1.83 129.9 43.0 127 31
122.5 60.0 93.8 23.0 94.2 17.0
48.5 33.2 36.0 27.0 32.8 20.0
0.62 0.98 0.43 0.6 1.75 2.5
4.7 3.1 4.3 1.1 4.3 1.7
90 9§ 88 6.4 88 4.2
6.7 6.9 5.9 3.4 6.4 4.2
9,451 4,662 8,829 3,601 8,167 3,019
0.03 0.01 0.26 0.54 0.09 0.11
151 20 160 20 162 17
43 10§ 45.2 7.7¶ 44.8 6.7
90 33 78 17 69 15
9.19 3.80 8.2 2.1 8.4 4.2
35 subjects. Within-group comparisons: †p 0.0001, ‡p 0.001, and §p 0.05 compared with
dl, and for the statistical analysis, we considered their CRP levels as 0.02 mg/dl. Between-groupWeigGain
(n  3
in
6.7
.9
3.4
3.5†
.1†
.6†
.7‡
.4†
7†
4†
5†
.83
.2§
1
.9†
,281§
.08
4
.3
4
.24§
of the
2 mg/lipoprotein.
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August 17, 2010:662–6 Fat Gain and Endothelial Dysfunctionat gainers. After an average weight gain of 4.1  0.20 kg,
f which80% was fat, total body, visceral, and subcutaneous
at area and total body fat percent increased significantly (all
values 0.0001). After an average of 3.6 kg weight loss at
ecovery, anthropometric and body composition measures
ecovered to baseline values (all p values 0.05). Neither
eight gain nor weight loss resulted in significant changes in
esting blood pressure or heart rate (Table 1).
In the fat gainers, FMD diminished significantly (9.1 
.0 vs. 7.6  3.2, p  0.003) and recovered to baseline
9.0  3.8) after losing the gained weight (Fig. 1). In the
eight maintainers, FMD remained unchanged during the
tudy (p  0.45) (Table 1).
Changes in endothelial function as measured by percent change
n FMD after weight gain were not significantly correlated with
hanges in cardiometabolic biomarkers (Table 2).
We found a significant and negative correlation between
ercent changes in FMD and total fat gain (rho  0.45,
 0.002) in the abdominal area. After analyzing visceral and
ubcutaneous fat separately, visceral (rho0.42, p 0.004)
ut not subcutaneous (rho  0.22, p  0.15) fat gain was
ignificantly related to reduction of FMD. Furthermore, the
agnitude of impairment in FMD was significantly higher in
ubjects who had greater increases in visceral fat (Fig. 2). Total
ody fat, BMI, waist circumference, and waist-to-hip ratio
ncrements were not related to changes in FMD.
iscussion
he important and novel finding of this study is that modest
at gain in normal-weight healthy young subjects under stan-
ardized conditions of diet and activity is associated with
Figure 1 Endothelial Function in Fat Gainers
Comparison of brachial artery flow-mediated dilation (FMD) at baseline,
after fat gain, and after subsequent fat loss (recovery) (n  35).ttenuated endothelial function, even in the absence of changesn blood pressure. Endothelial function recovers after reversal of
he fat gain. Importantly, endothelial dysfunction is significantly
inked to visceral but not to subcutaneous fat gain.
To our knowledge, this is the first randomized controlled
ongitudinal study to demonstrate that in normal-weight
ealthy young subjects, modest visceral fat gain is associated
ith blunted FMD. Endothelial dysfunction is considered
n early marker of atherosclerotic disease, with important
linical implications (1,4,10–12). We found that FMD was
lunted after weight gain and recovered after the restoration
f normal weight, suggesting that changes in endothelial
unction are reversible, at least in the short term. Moreover,
ur data suggest that the development of endothelial dys-
unction precedes any blood pressure increase.
orrelation Coefficients (Rho)etween Perc nt Change in FMDnd Chang s i Cardiometabolic Biomarkers
Table 2
Correlation Coefficients (Rho)
Between Percent Change in FMD
and Changes in Cardiometabolic Biomarkers
Biomarker
% Change in FMD
Rho p Value
Leptin 0.08 0.66
Adiponectin 0.16 0.39
Insulin 0.05 0.77
CRP 0.12 0.68
Glucose 0.12 0.53
HOMA-IR 0.14 0.47
Total cholesterol 0.12 0.51
LDL 0.17 0.34
HDL 0.07 0.70
Triglycerides 0.18 0.33
OMA-IR  homeostasis model assessment of insulin resistance; LDL  low-density lipoprotein;
ther abbreviations as in Table 1.
Figure 2 Endothelial Dysfunction by Tertiles of
Visceral Fat Gain in the Fat Gain Group
Endothelial dysfunction (percent reduction in flow-mediated dilation [FMD])
by tertiles of visceral fat gain in fat gainers (n  35).
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Fat Gain and Endothelial Dysfunction August 17, 2010:662–6Interestingly, the magnitude of attenuation in endothelial
unction in healthy subjects, who gained mainly visceral fat,
s very similar to that observed with smoking, diabetes, and
ging (13,14). Modest short-term weight gain is often an
ccepted consequence of the holiday season. Our study
rovides evidence that modest fat gain affects endothelial
unction, arguing against our cultural permissiveness toward
eight gain or “going up a clothing size” as a “normal”
henomenon and strengthens the case for weight control as
means of attenuating cardiovascular risk.
The selective interaction between endothelial dysfunction
nd visceral fat gain observed is consistent with epidemio-
ogic studies linking cardiovascular risk to central measures
f obesity (15,16). Mechanisms linking visceral adiposity to
ncreased risk include higher levels of adipokines and
roinflammatory molecules (17,18). Moreover, free fatty
cid flux of visceral fat is biochemically distinct and may be
ore deleterious to the liver, predisposing to insulin resis-
ance (18) and perhaps endothelial dysfunction. Previous
tudies have shown an association between adiponectin and
ndothelial function (19,20). However, in our study popu-
ation, FMD was not associated with changes in leptin,
diponectin, and CRP, which is in accordance with a recent
tudy that did not find a significant association between
MD and adiponectin levels in obese subjects (21).
Potential limitations of the study include that the intentional
eight gain may not fully reflect the long-term gradual changes
ccurring in uncontrolled conditions in the general population,
uggesting some caution in interpreting the results.
onclusions
odest fat gain causes endothelial dysfunction in normal-weight,
ealthy young adults, even in the absence of changes in blood
ressure and heart rate. Endothelial function recovers after the
eversal of fat gain. Visceral fat gain is significantly correlated with
mpaired FMD. Endothelial dysfunction secondary to visceral fat
ain may be an important mechanism linking central obesity to
ncreased cardiovascular morbidity and mortality.
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